GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $321 | +33.2% | 167 | 0.0% | 0.00% | – |
Q2 2023 | $241 | -31.3% | 167 | 0.0% | 0.00% | – |
Q1 2023 | $351 | +85.7% | 167 | 0.0% | 0.00% | – |
Q4 2022 | $189 | – | 167 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 167 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 129,488 | $271,925 | 0.08% |
Geneos Wealth Management Inc. | 427,400 | $897,540 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $25,200 | 0.02% |
Vivaldi Capital Management LP | 19,261 | $40,448 | 0.01% |
Beacon Capital Management, LLC | 12,605 | $26,471 | 0.01% |
Atria Wealth Solutions, Inc. | 263,300 | $552,930 | 0.01% |
Wealthspire Advisors, LLC | 183,862 | $386,111 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $10,466 | 0.01% |
OSAIC HOLDINGS, INC. | 1,271,760 | $2,670,656 | 0.01% |
Ameritas Advisory Services, LLC | 45,302 | $94,856 | 0.01% |